Teva Pharmaceutical Industries Ltd. ADR-1.50% $19.99B ...

Morgan Stanley initiated coverage of GSK (GSK) with an Equal Weight rating and 1,450 GBp price target The shares trade at an inexpensive valuation but the company’s mid- to longer-term growth ...

In 2025, 4K resolution is the standard for high-quality media, and compared to older high-definition (HD) and standard definition (SD) resolutions, it's a big improvement. Many of the best TVs ...

Bearish flow noted in GSK (GSK) Pharma with 2,330 puts trading, or 1.1x expected. Most active are 2/14 weekly 36 puts and 2/28 weekly 36 puts, with total volume in those strikes near 1,600 contracts.

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK chief executive Emma Walmsley said a slowdown in vaccine sales is expected for the second quarter, but whether that continues throughout the remainder of the year will depend on how long it ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Feb 14 (Reuters) - Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK (GSK.L), opens ... lawsuits after several high-profile companies said they ...